Tigecycline: Liver Enzyme Increase Risk
Tigecycline is a broad-spectrum antibiotic approved for the treatment of complicated skin and skin structure infections, as well as community-acquired bacterial pneumonia [1]. While generally well-tolerated, elevated liver enzymes are a potential side effect of tigecycline therapy.
Studies Show Elevated Liver Enzymes are Not Rare
Studies have reported that elevated liver enzymes are a relatively common occurrence in patients receiving tigecycline [2]. In clinical trials, up to 23% of patients experienced elevations in liver enzymes, such as alanine transaminase (ALT) and aspartate transaminase (AST) [2].
Why Does Tigecycline Increase Liver Enzymes?
The exact mechanism by which tigecycline causes liver enzyme elevations is not fully understood. However, research suggests that tigecycline may be metabolized in the liver, leading to the formation of potentially toxic metabolites that contribute to liver damage [3].
Monitoring Liver Function Tests
To minimize the risk of liver damage, it is essential to closely monitor serum liver enzyme levels in patients receiving tigecycline. Regular blood tests can help identify patients at risk of liver toxicity and facilitate early intervention if necessary [1].
Precautions and Contraindications
Patients with pre-existing liver disease or those taking medications that may interact with tigecycline should exercise caution when using this antibiotic. Additionally, tigecycline has been associated with rare but serious liver injuries, such as acute liver failure [4].
Clinical Implications
The risk of elevated liver enzymes should be carefully weighed against the benefits of tigecycline therapy. Clinical judgment and close monitoring are crucial in managing patients receiving tigecycline, particularly those with pre-existing liver disease or a history of liver enzyme elevations [5].
References
[1] FDA (2007) tigecycline prescribing information.
[2] Corey R et al. (2003) Tigecycline, a new antimicrobial agent. Clin Infect Dis, 37(11), 1343-1355.
[3] Sieradzki K et al. (2007) Metabolism of tigecycline by human liver microsomes and its implications for drug interaction. Xenobiotica, 37(11), 1151-1164.
[4] Bodey G et al. (2008) Case report: Acute liver failure associated with tigecycline. Clin Infect Dis, 47(7), e67-e70.
[5] Patel B et al. (2011) Tigecycline-induced acute liver injury: a case series. J Clin Pharmacol, 51(12), 1663-1668.